Human BCL10 (B-Cell Lymphoma/Leukemia 10) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-00300P

SDS-PAGE analysis of Human BCL10 (B-Cell Lymphoma/Leukemia 10) - Recombinant Protein, CAT# BLT-00300P, showing >95% purity under 15% SDS-PAGE (Reduced)
Human BCL10 (B-Cell Lymphoma/Leukemia 10) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-00300P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human B-Cell CLL/Lymphoma 10 (Bcl10) Protein |
Product Overview | This recombinant human B-Cell CLL/Lymphoma 10 (Bcl10) protein includes amino acids 1-233aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | O95999 |
Recommended Name | B-cell lymphoma/leukemia 10 |
Gene Name | BCL10 |
Synonyms | B-cell lymphoma/leukemia 10, c-E10, CARMEN, CIPER, CLAP, mE10. |
Species | Human |
Predicted Molecular Mass | 30 kDa |
Expression System | E.coli |
Expression Range | 1-233aa |
Tag | N-6His |
Purity | >95% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Apoptosis |
Target Function | Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation. Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines. Recruited by activated CARD domain-containing proteins: homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex. This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines. Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity. Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK. |
Subcellular Location | Cytoplasm, perinuclear region. Membrane raft. |
Associated Diseases | Immunodeficiency 37 (IMD37); Lymphoma, mucosa-associated lymphoid type (MALTOMA) |
Tissue Specificity | Ubiquitous. |